Background {#Sec1}
==========

Stroke incidence has declined in developed countries over the past decades, but it has increased in China, becoming the leading cause of death in rural areas and the third leading cause of death in urban areas \[[@CR1]--[@CR4]\]. Furthermore, stroke is now the leading cause of death in China overall, accounting for \> 40% of all-cause deaths \[[@CR5]\].

Ischemic stroke is characterized by highly differentiated subtypes \[[@CR6], [@CR7]\]. Small artery occlusion (SAO) is a major ischemic stroke subtype that occurs more commonly in Asian than Western populations \[[@CR8], [@CR9]\]. A higher prevalence of small-vessel occlusion was observed in Chinese stroke patients than in Caucasian stroke patients (33.1% vs. 19.3%) \[[@CR10]\].

Stroke has a greater impact on women than on men due to the higher longevity in women \[[@CR11]--[@CR15]\]. However, sex differences in outcomes and relevant risk factors among patients with SAO are unclear. Thus, we aimed to assess differences in outcomes and risk factors according to sex among patients with SAO in a large hospital-based stroke registry in China.

Methods {#Sec2}
=======

Patient selection {#Sec3}
-----------------

This study used data from a stroke registry from three hospitals in Tianjin, China: Tianjin Medical University General Hospital (a university hospital that primarily admits patients from urban areas and patients transferred from rural areas), Tianjin Huanhu Hospital (a neurological specialized hospital that primarily admits patients from urban and rural areas in Tianjin), and Tianjin Haibin People's Hospital (an oilfield staff hospital that primarily admits patients working in the Dagang oilfield and their family members).

All acute ischemic stroke patients diagnosed with SAO according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification from May 2005 to September 2014 were included in this study. In this study, patients who died before the imaging examination and patients with transient ischemic attack were excluded. Information on clinical characteristics and outcomes of all patients with ischemic stroke who were admitted to the stroke units in these three hospitals within 72 h after stroke onset was collected.

The study was approved by the ethics committee at Tianjin Huanhu Hospital and was found to conform to the Declaration of Helsinki regarding use of human subjects; written informed consent was obtained from each patient during recruitment.

SAO diagnosis criteria {#Sec4}
----------------------

SAO was diagnosed according to the following criteria \[[@CR16]\]: (1) patients presented with one of the traditional clinical lacunar syndromes and no evidence of cerebralcortical dysfunction; (2) the infarction was located in the subcortex or brainstem and was \< 1.5 cm in diameter on computed tomography/magnetic resonance imaging; (3) a previous history of diabetes mellitus (DM) or hypertension supported the clinical diagnosis; (4) potential cardiac embolism was excluded; and (5) \< 50% stenosis in an ipsilateral artery was observed.

Clinical features and risk factors {#Sec5}
----------------------------------

Clinical features included stroke subtypes, stroke severity, stroke risk factors, neurological function score, and laboratorial values. Stroke subtypes were classified according to Oxfordshire Community Stroke Project (OCSP) criteria on admission; subtypes included total anterior circulation infarct, partial anterior circulation infarct, lacunar infarct, and posterior circulation infarct (POCI) \[[@CR17]\]. Stroke severity was categorized into three groups according to National Institutes of Health Stroke Scale (NIHSS) score: mild (NIHSS score ≤ 7), moderate (NIHSS score 8--16), and severe (NIHSS score ≥ 17) \[[@CR18]\]. Stroke risk factors included hypertension (defined as systolic blood pressure ≥ 140 mmHg/diastolic blood pressure ≥ 90 mmHg, self-reported previous history of hypertension, or using antihypertension drugs), DM (defined as fasting plasma glucose ≥7 mmol/L, self-reported history of DM, or using hypoglycemic medications at discharge), atrial fibrillation (AF; defined as self-reported history of AF, confirmed by at least one electrocardiogram, or the presence of the arrhythmia during hospitalization), obesity (defined as body mass index ≥ 30 kg/m^2^), current smoking (≥ 1 cigarette per day for more than 1 year), and alcohol consumption (drinking alcohol at least once per week for more than 1 year).

The NIHSS score, modified Rankin Scale (mRS) score, and Barthel Index (BI) were evaluated on admission, at discharge, and at 3 and 12 months after stroke. Moreover, the fasting levels on admission of total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and fasting plasma glucose (FPG) were recorded in this study.

Outcome assessments {#Sec6}
-------------------

Outcomes included mortality, dependency, and recurrence rates 3 months after stroke. Mortality was defined as all-cause cumulative death at the corresponding follow-up time point. Recurrence was defined as all new-onset vascular events, including stroke, myocardial infarction, and venous thrombosis. Dependency was defined as an mRS score \> 2 \[[@CR18]\]. Follow-up was conducted according to a predetermined procedure; the same trained senior neurologist collected data at 3 months. Follow-up was performed for all patients by face-to-face interview, except for patients who were re-examined in their local hospitals, who completed follow-up by telephone (accounted for 2.1%).

Management and quality control {#Sec7}
------------------------------

This study was a hospital-based follow-up study. There were three groups overseeing the management of all patients into this stroke registry system. The assessment group consisted of five trained senior neurologists who assessed neurological score during hospitalization. The follow-up group consisted of three senior trained neurologists who performed the reexamination, including evaluating neurological scores, managing risk factors, and directing treatment and rehabilitation. The quality control group consisted of the director of the department of neurology, an epidemiologist, and a data management specialist, who conducted a sampled confirmation for 20% of all patients every month.

Stroke treatment {#Sec8}
----------------

The most common cause of SAO is hypertension; antihypertensives were prescribed for patients as appropriate. Simultaneously, statins were administered to those with dyslipidemia or evidence of atherosclerosis, and anticoagulants were administered to patients who SAO was caused by AF. Generally, thrombolytic therapy was administered for revascularization within 4 h of stroke, and antithrombotic therapy and treatment for applicable risk factors (such as hypertension, diabetes, dyslipidemia) were given during the acute stage of stroke.

Statistical analysis {#Sec9}
--------------------

Continuous variables are presented as means with standard deviations (age and TC, TG, HDL-C, LDL-C, and FPG levels) or as medians with interquartile ranges (NIHSS, BI, mRS) and were compared between men and women using Student's *t* test or the Mann-Whitney *U* test. Categorized variables are presented as numbers of cases (rates) and were compared between men and women using the chi-square test. The factors of recurrence were assessed by multivariate stepwise regression after adjusting for covariates (the *P* value threshold for remaining in the equation was 0.05, while that for removing the covariate from the equation was 0.10); results are presented using adjusted odds ratios (OR) with 95% confidence intervals (CI). All statistical analyses were performed using SPSS version 19.0 (SPSS Inc., Chicago, IL), and a two-tailed *P* value \< 0.05 generally indicated statistical significance, but statistical significance in the multivariate analysis was defined as *P* value \< 0.05/number of groups. The thresholds of statistical significance were *P* \< 0.0125 for OCSP classification and *P* \< 0.0167 for stroke severity.

Results {#Sec10}
=======

Patient selection {#Sec11}
-----------------

A total of 11,330 patients with acute ischemic stroke were recruited during the study period, and 2524 patients with SAO were included in this study after excluding 8679 non-SAO patients and 127 patients without TOAST classification data. The response rate was 98.9% 3 months after stroke. Moreover, there were 27 SAO patients (1.1%) lost to follow-up 3 months after stroke. We excluded these patients from the analysis (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Flow diagram of participants

Sex differences in clinical features among patients with SAO {#Sec12}
------------------------------------------------------------

Of these patients with SAO, there were 1696 men (67.2%) and 828 women (32.8%), with mean ages of 64.10 years overall, 61.93 years for men, and 65.62 years for women (*P* \< 0.001). Men were more likely than women to be \< 75 years (84.6% vs. 79.6%), have mild stroke (84.1% vs. 79.6%), smoke (50.4% vs. 12.0%), and consume alcohol (27.1% vs. 1.8%; all *P* \< 0.001). The prevalence rates of DM and obesity were higher in women than in men. Moreover, women had worse neurological function than men on admission, and average TC, HDL-C, and LDL-levels C were higher in women than in men (Table [1](#Tab1){ref-type="table"}).Table 1Sex differences in clinical features and risk factors among patients with SAOCharacteristicsMen\
(*n* = 1696)Women (*n* = 828)*t*/*χ*^2^df*P*Age, years, means (SD)61.93 (11.41)65.62 (10.86)7.7362522\< 0.001Age group, *n* (%)34.8281\< 0.001 \< 75 years1435 (84.6)620 (74.9) ≥ 75 years261 (15.4)208 (25.1)OCSP classification, *n* (%) PACI642 (37.9)354 (42.8)5.5921ns TAPI30 (1.8)13 (1.6)0.1311ns LACI473 (27.9)220 (26.6)0.4861ns POCI551 (32.5)241 (29.1)2.9551nsStroke severity\*, *n* (%) Mild1427 (84.1)656 (79.6)7.93010.005 Moderate234 (13.8)141 (17.1)4.8101ns Severe35 (2.1)27 (3.3)3.4001nsRisk factors, *n* (%) Hypertension1278 (75.4)638 (77.1)0.8791ns Diabetes514 (30.3)303 (36.6)10.04810.002 Atrial fibrillation41 (2.4)18 (2.2)0.1451ns Obesity139 (8.2)152 (18.4)56.3251\< 0.001 Current smoking854 (50.4)99 (12.0)349.0411\< 0.001 Alcohol drinking459 (27.1)15 (1.8)232.5991\< 0.001Neurological function^†^ NIHSS4 (4)4 (5)15.9281\< 0.001 mRS2 (3)3 (3)12.9081\< 0.001 BI75 (45)70 (45)33.1291\< 0.001Laboratory testing, mmol/L, means (SE) FPG6.37 (2.72)6.58 (2.73)1.6331954ns TC4.74 (0.95)5.23 (1.04)11.2912423\< 0.001 TG1.64 (0.99)1.71 (0.96)1.1532423ns HDL-C1.04 (0.59)1.15 (0.29)4.6502407\< 0.001 LDL-C2.92 (0.78)3.15 (0.83)6.5942405\< 0.001\*There were 4 female patients for whom NIHSS scores were not obtained^†^Data presented as medians with interquartile ranges

Sex differences in outcomes among patients with SAO {#Sec13}
---------------------------------------------------

As shown in Table [2](#Tab2){ref-type="table"}, there were worse outcomes in men than in women 3 months after stroke, with mortality, recurrence, and dependency rates of 1.9%, 3.8%, and 8.9% in men and 0.6%, 1.7%, and 6.2% in women, respectively (*P* \< 0.05).Table 2Sex differences in outcomes 3 months after stroke among patients with SAOOutcomesMenWomen*t*/*χ*^2^df*P*Mortality, *n* (%)6.33810.012 Numbers for followed-up1678819 Death case32 (1.9)5 (0.6)Recurrence, *n* (%)7.57110.006 Numbers for followed-up1646812 Recurrent case62 (3.8)14 (1.7)Dependency, *n* (%)5.46910.019 Numbers for followed-up1678819 Dependency case150 (8.9)51 (6.2)

Sex differences in factors associated with outcomes among patients with SAO in the multivariate stepwise regression analysis {#Sec14}
----------------------------------------------------------------------------------------------------------------------------

In the multivariate analysis, the hazard of mortality 3 months after stroke was associated with older age, moderate stroke, low TG level, and elevated FPG level in men. Older age and elevated LDL-C level were independent risk factors for recurrence, with ORs (95% CIs) of 1.04 (1.01, 1.07; *P* = 0.008) for age and 1.80 (1.25, 2.60; *P* = 0.002) for LDL. Moreover, older age, moderate and severe stroke, and high TC and FPG levels were risk factors for dependency 3 months after stroke. In women, older age was a common risk factor of recurrence and dependency 3 months after stroke. Moreover, LDL-C level was associated with mortality 3 months after SAO, and TC level was independently associated with recurrence (Table [3](#Tab3){ref-type="table"}).Table 3Factors associated with outcomes 3 months after stroke among male and female patients with SAO by multiple stepwise regression analysisRisk factorsReferenceMortalityRecurrenceDependencyOR (95%CI)*χ* ^2^df*P*OR (95%CI)*χ* ^2^df*P*OR (95%CI)*χ* ^2^df*P*Men Age--1.06 (1.02, 1.11)7.28710.0231.04 (1.01, 1.07)6.80410.0081.05 (1.03, 1.07)20.3971\< 0.001 SeverityMild  Moderate4.21 (1.59, 11.18)8.33210.004----2.45 (1.48, 4.05)12.1891\< 0.001  Severe2.88 (0.31, 26.91)0.91310.355----5.21 (1.68, 16.09)8.20910.004 ObesityNo0.39 (0.15, 1.01)3.72710.054 TC--------1.33 (1.07, 1.64)7.57410.009 TG--0.27 (0.10, 0.72)6.89410.009-------- LDL-C--1.80 (1.25, 2.60)9.83710.002 FPG--1.46 (1.27, 1.67)28.3881\< 0.001----1.16 (1.09, 1.24)19.4661\< 0.001Women Age------1.06 (1.02, 1.09)10.53910.0011.05 (1.02, 1.08)10.04710.002 TC--0.67 (0.46, 0.97)4.48910.034 LDL-C--0.15 (0.03, 0.78)5.08610.024

Sex differences in clinical features and risk factors among patients with large artery atherothrombosis (LAA) {#Sec15}
-------------------------------------------------------------------------------------------------------------

Table [4](#Tab4){ref-type="table"} displays the sex differences in clinical features, risk factors, and outcomes 3 months after stroke among patients with LAA. Similar to the findings with SAO, male patients with LAA were more likely than female patients to have mild stroke, smoke, and drink alcohol; female patients with LAA were more likely than male patients to be older and have DM, obesity, poor neurological function, and high TC, HDL-C, and LDL-C levels (all *P* \< 0.05). In contrast to the findings with SAO, male patients with LAA were more likely than female patients to have POCI; the frequency of POCI was 37.1% in men and 33.4% in women (*P* = 0.002). Female patients with LAA were more likely than male patients to have severe stroke (12.3% vs. 9.3%; *P* \< 0.001), hypertension (77.1% vs. 75.4%), and high FPG and TG levels (all *P* \< 0.001). Moreover, there were significant sex differences in dependency rates 3 months after stroke among patients with LAA.Table 4Sex differences in clinical features and risk factors among patients with LAACharacteristicsMen\
(*n* = 1696)Women\
(*n* = 828)*t*/*χ*^2^df*P*Age, years, means (SD)62.79 (11.52)67.26 (10.38)16.3487598\< 0.001Age group, *n* (%)69.0981\< 0.001 \< 75 years4171 (81.4)1808 (73.1) ≥ 75 years954 (18.6)667 (26.9)OCSP classification, *n* (%) PACI2927 (57.1)1509 (61.0)10.22010.001 TAPI279 (5.4)127 (5.1)0.3231ns LACI20 (0.4)12 (0.5)0.3561ns POCI1899 (37.1)827 (33.4)9.61110.002Stroke severity, *n* (%) Mild3262 (63.7)1419 (57.3)28.2511\< 0.001 Moderate1386 (27.0)752 (30.4)7.3421\< 0.001 Severe476 (9.3)304 (12.3)16.2331\< 0.001Risk factors, *n* (%) Hypertension1278 (75.4)638 (77.1)104.8601\< 0.001 Diabetes1576 (30.8)957 (38.7)47.0601\< 0.001 Atrial fibrillation181 (3.5)133 (5.4)14.2971\< 0.001 Obesity471 (9.2)508 (20.5)191.0821\< 0.001 Current smoking2704 (52.8)374 (15.1)981.77110.002 Alcohol drinking1448 (28.3)25 (1.0)792.7931\< 0.001Neurological function, median (interquartile range) NIHSS6 (7)6 (8)36.51110.001 mRS3 (2)4 (6)51.4131\< 0.001 BI60 (50)50 (50)62.0251\< 0.001Laboratory value, mmol/L, means (SE) FPG6.50 (2.67)6.91 (2.86)5.3765733\< 0.001 TC4.76 (1.04)5.233 (1.15)21.0857253\< 0.001 TG1.58 (1.00)1.74 (1.27)5.8087253\< 0.001 HDL-C1.02 (0.27)1.14 (0.31)16.7347210\< 0.001 LDL-C2.96 (0.84)3.27 (0.91)13.9897203\< 0.001Prognosis at 3 months after stroke, *n* (%) Mortality355 (7.1)194 (8.0)2.0111ns Recurrence194 (4.2)89 (4.0)0.1071ns Dependency753 (15.0)416 (17.2)5.60410.018

Discussion {#Sec16}
==========

This is the first report to describe sex differences in outcomes and relevant risk factors among patients with SAO. We demonstrated that mortality, recurrence, and dependency rates 3 months after stroke were significantly higher in men than in women. Older age was a common risk factor of outcomes both in men and in women. Low TG level and high FPG level were independent risk factors for mortality; high LDL-C level were associated with recurrence in men. Moreover, in men, moderate and severe stroke, and high TC and FPG levels were risk factors for dependency. Negative associations were found between LDL-C level and the risk of mortality and between TC level and the risk of recurrence. Inconsistent with the findings for SAO, there were no significant sex differences in mortality and recurrence rates 3 months after stroke among patients with LAA.

The prevalence rates of small-vessel occlusion and internal carotid artery stenosis are high in Asian countries \[[@CR8]\]. However, there are limited reports on SAO; moreover, the reported outcomes among patients with SAO have been controversial. Most previous studies demonstrated favorable short-term outcomes among SAO patients \[[@CR19], [@CR20]\] and favorable long-term outcomes among elderly SAO patients \[[@CR17], [@CR21]\]. Moreover, young patients with SAO experienced low mortality rates over a 5-year follow-up period \[[@CR22]\]. In contrast to these studies, a 10-year follow-up study reported a worse prognosis for those with lacunar stroke compared to the general population \[[@CR23]\].

Distinct from previous studies, in the present study, we assessed sex differences in clinical features, outcomes, and associated factors among SAO patients. We found that mortality, recurrence, and dependency rates were higher in men than in women. There were poor outcomes in men 3 months after stroke. Simultaneously, lower prevalence rates of DM and obesity were observed in male SAO patients.

A few studies have investigated the association between DM and the long-term prognosis of patients after acute ischemic stroke \[[@CR24], [@CR25]\]; however, the evidence for this association remains controversial. A report from China demonstrated that DM independently predicted poor outcomes within 6 months in Chinese patients after acute ischemic stroke \[[@CR26]\]. Several studies have reported that DM was associated with a higher stroke mortality rate \[[@CR27], [@CR28]\], but this was not observed in other studies \[[@CR29], [@CR30]\]. Furthermore, many studies have indicated that DM is an important predictive factor for dependency \[[@CR28], [@CR31], [@CR32]\] and recurrence rates \[[@CR33]--[@CR35]\]. However, several studies have shown no remarkable relationship between DM and stroke prognosis \[[@CR27], [@CR29], [@CR36]\]. In addition, one study reported that a lower neurological deficit at admission was observed in stroke patients with DM \[[@CR37]\]. A recent study indicated that elevated glycosylated hemoglobin level on admission was adversely associated with functional outcomes 3 months after stroke among patients with SAO \[[@CR38]\]; both fasting glucose and DM were associated with an increased risk of stroke in patients diagnosed with a minor stroke or transient ischemic attack \[[@CR39]\].

In this study, we found no association in men or women between a previous history of DM and stroke outcome; however, FPG level was positively associated with mortality and dependency in male SAO patients. Moreover, while we found a higher prevalence of DM in women than in men, women had lower mortality, recurrence, and dependency rates. The effective management and control of FPG levels in patients with DM can improve outcomes for female stroke patients, and this may have contributed to the lower risk of poor outcomes among female SAO patients in this study.

Furthermore, the relationship between lipid levels and outcomes among SAO patients remains unclear. In a hospital-based study, low serum TC levels were associated with poor functional outcomes in ischemic stroke patients who had received pre-stroke statin treatment, and the short-term and long-term mortality rates were significantly higher in patients with low cholesterol levels \[[@CR40]\]. However, our previous findings suggested that there was no significant association between low cholesterol levels and mortality after stroke \[[@CR41]\].

In the present study, among male SAO patients, a positive association between TC level and dependency 3 months after stroke was observed, but there was a negative association between TG level and mortality 3 months after stroke. Statins might have a neuroprotective effect \[[@CR42]--[@CR44]\], but the timeliness of statin therapy may explain why the high TC level increased the risk of dependency among SAO patients 3 months after stroke. A long-term follow-up study is needed in the future to explore the impact of TC on outcomes of SAO patients.

There were several limitations in this study. First, this study was conducted in Tianjin, China, and thus represents a limited population. Second, information regarding medication usage before stroke onset was lacking, and this may have affected evaluation of the association between risk factors and outcomes. Finally, all patients were recruited from stroke units; patients with fatal strokes or silent strokes were excluded from this study, and this could have impacted the assessment of outcomes.

Conclusion {#Sec17}
==========

This is the first report to describe sex differences in outcomes and relevant determinants among patients with SAO. We demonstrated that mortality, recurrence, and dependency rates 3 months after stroke were significantly higher in men than in women. Older age, severe stroke, and high FPG level were independent risk factors for mortality and dependency in men. Moreover, in men, TG level was negatively associated with mortality, TC level was positively associated with dependency, and LDL-C level was an independent risk factor for recurrence. A negative association between LDL-C level and mortality was found in women. In addition, older age was positively associated with the risk of recurrence and dependency in women, and TC level was negatively associated with the risk of recurrence. These findings suggest that it is crucial to address the management of FPG and TC levels among patients with SAO, especially male patients, to reduce the burden of stroke in China.
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